Zidovudine, lamivudine and dolutegravir (AXD) Relative to Tenofovir, lamivudine and dolutegravir (TXD) In Second Line Antiretroviral Therapy (ARTIST) Trial: a randomised controlled trial
Principal investigator
-
Location
-
Topic
-
Methodology
-
ReferenceOCB1901
Purpose of study
Purpose of study
As the HIV epidemic matures and more patients are initiated on antiretroviral treatment, focus is on ensuring that those on antiretroviral therapy are virologically suppressed. The strategy to support virological suppression on second-line include...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Publication added by Petros Isaakidis
4th May 2023 -
Protocol added by Petros Isaakidis
17th April 20231179-protocol-2023-04-17.doc445 KB -
Other added by Petros Isaakidis
17th April 20231179-other-2023-04-17.pdf121 KB
Documents
-
1179-other-2023-04-17.pdf 121 KB
-
1179-protocol-2023-04-17.doc 445 KB
Publications
-
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trialZhao, Ying "–" F1000 Research Ltd "(2021)"
Previous study
Next study